<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>rivati Archivi - Contropiano</title>
	<atom:link href="https://contropiano.org/tag/rivati/feed" rel="self" type="application/rss+xml" />
	<link>https://contropiano.org/tag/rivati</link>
	<description>Giornale comunista online</description>
	<lastBuildDate>Thu, 23 Jun 2016 08:34:44 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>Farmaci antitumore? Solo per ultra ricchi, e non a lungo</title>
		<link>https://contropiano.org/news/news-economia/2016/06/23/farmaci-antitumore-solo-ultra-ricchi-non-lungo-080794</link>
					<comments>https://contropiano.org/news/news-economia/2016/06/23/farmaci-antitumore-solo-ultra-ricchi-non-lungo-080794#comments</comments>
		
		<dc:creator><![CDATA[Redazione Contropiano]]></dc:creator>
		<pubDate>Thu, 23 Jun 2016 08:29:22 +0000</pubDate>
				<category><![CDATA[Economia]]></category>
		<category><![CDATA[antitumorali]]></category>
		<category><![CDATA[costi]]></category>
		<category><![CDATA[europa]]></category>
		<category><![CDATA[farmaci]]></category>
		<category><![CDATA[multinazionali]]></category>
		<category><![CDATA[prezzi]]></category>
		<category><![CDATA[profitto]]></category>
		<category><![CDATA[pubblico]]></category>
		<category><![CDATA[ricerca]]></category>
		<category><![CDATA[rivati]]></category>
		<category><![CDATA[sistema sanitario]]></category>
		<category><![CDATA[stati]]></category>
		<category><![CDATA[tecnologie]]></category>
		<category><![CDATA[USA]]></category>
		<guid isPermaLink="false">http://contropiano.org/?p=80794</guid>

					<description><![CDATA[<p>Quando i problemi diventano giganteschi, anche in ambito mainstream si comincia a ragionare in modo più serio sulle soluzioni. Ovvero: gli uomini si pongono solo i problemi che possono essere risolti, ma solo quando sono con le spalle al muro. Un ottimo e sintetico articolo apparso sul Corriere della Sera, [&#8230;]</p>
<p>L'articolo <a href="https://contropiano.org/news/news-economia/2016/06/23/farmaci-antitumore-solo-ultra-ricchi-non-lungo-080794">Farmaci antitumore? Solo per ultra ricchi, e non a lungo</a> su <a href="https://contropiano.org">Contropiano</a>.</p>
]]></description>
		
					<wfw:commentRss>https://contropiano.org/news/news-economia/2016/06/23/farmaci-antitumore-solo-ultra-ricchi-non-lungo-080794/feed</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
	</channel>
</rss>
